oregon proposes 17 tax on hemp derived cannabinoi 7

Oregon Proposes 17% Tax on Hemp-Derived Cannabinoid Products in 2026 Session

CED Clinical Relevance
#15 Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
PolicyHempIndustryDosing
Why This Matters
Oregon wants to tax hemp CBD and cannabinoid products at the same 17% rate as marijuana, which could significantly raise prices on the wellness products you buy.
Clinical Summary

Oregon’s 2026 short session (35 days) includes HB 4139, which would impose a 17% retail sales tax on industrial hemp-derived cannabinoid products—matching the marijuana tax rate. The bill also defines ‘container’ and ‘industrial hemp-derived cannabinoid product,’ requires individually packaged edibles capped at 10mg per piece, and mandates criminal background checks for hemp handlers. Oregon continues leading states in tightening hemp-cannabis regulatory alignment.

Dr. Caplan’s Take
“Oregon is treating hemp cannabinoids like cannabis without giving hemp businesses the benefits of being in the licensed cannabis system,that’s taxation without representation in its purest modern form.”
Clinical Perspective

OREGON’S SIGNAL: STATES ARE TAXING HEMP CANNABINOIDS LIKE MARIJUANA

Oregon’s 2026 short session includes HB 4139, a bill that would impose a 17% retail sales tax on hemp-derived cannabinoid products—the same rate levied on marijuana in the state’s OLCC system.

The bill also defines ‘container’ and ‘industrial hemp-derived cannabinoid product,’ requires edibles to be individually packaged with a 10mg cap per piece, mandates criminal background checks for hemp handlers, and authorizes unannounced inspections by the ODA with law enforcement.

This matters beyond Oregon because it represents a broader trend: states aren’t waiting for the federal government to figure out hemp cannabinoid regulation. They’re treating these products like what they functionally are—cannabis products sold outside the licensed cannabis system.

Oregon was among the first states to ban artificially derived cannabinoids like delta-8. It maintains a 21+ age requirement for consumable hemp products. And now it wants tax parity.

For cannabinoid businesses operating in multiple states, this reinforces the central challenge of 2026: you’re navigating a federal ban, a patchwork of state regulations, and now state-level tax regimes that treat you like a cannabis company—without giving you the benefits of being in the licensed cannabis system.

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →